More recently, highly specific and sensitive oxidative cholesterol metabolites for NP-C have been identified.30 This ‘oxysterol test’ can be performed on a plasma sample and is now used as the first-line diagnostic test with subsequent genetic confirmation at one of the principal UK reference laboratories for lysosomal storage disorders. This evidence concerns the gene NPC1 and lysosomal storage disease.